Timothy Kelly
Chief Tech/Sci/R&D Officer chez CARIBOU BIOSCIENCES, INC.
Profil
Timothy P.
Kelly is currently the Chief Technology Officer at Caribou Biosciences, Inc. He previously worked as the Chairman & Chief Executive Officer at Oxford Biomedica Solutions LLC, Senior Director-International Operations at Biogen, Inc., Head-Technical Operations at Sarepta Therapeutics, Inc., Senior Vice President & Head-Biologics Operating at Shire Plc, and Head-Technical Operations at UCB SA. He also served as the Chief Operating Officer at Homology Medicines, Inc. from 2021 to 2022.
Mr. Kelly received his undergraduate degree from the United States Air Force Academy and his MBA from Troy University.
Postes actifs de Timothy Kelly
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 07/01/2024 |
Anciens postes connus de Timothy Kelly
| Sociétés | Poste | Fin |
|---|---|---|
| Q32 BIO INC. | Chief Operating Officer | 10/03/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2017 |
| SHIRE | Corporate Officer/Principal | 01/01/2017 |
| UCB | Corporate Officer/Principal | 01/01/2009 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Formation de Timothy Kelly
| United States Air Force Academy | Undergraduate Degree |
| Troy University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| UCB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Oxford Biomedica Solutions LLC
 Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Oxford Biomedica Solutions LLC is a development partner that offers a plug and play platform for partners to achieve high titer and high product quality vector. The platform has already been proven with six separate new product inds and ctas. The American company's approach to AAV manufacturing is through continuous innovation to ensure they are delivering the highest product quality and efficacy to patients. The CEO of the joint venture company is Timothy P. Kelly. | Producer Manufacturing |
